These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 36341366)

  • 21. Adoptive Transfer of Monocytes Sorted from Bone Marrow.
    Laoui D; Van Overmeire E; Abels C; Keirsse J; Van Ginderachter JA
    Bio Protoc; 2019 Jan; 9(1):e3134. PubMed ID: 33654762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro.
    Estko M; Baumgartner S; Urech K; Kunz M; Regueiro U; Heusser P; Weissenstein U
    BMC Complement Altern Med; 2015 Apr; 15():130. PubMed ID: 25902944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
    Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
    Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Models for Monocytic Cells in the Tumor Microenvironment.
    Lee SWL; Adriani G; Kamm RD; Gillrie MR
    Adv Exp Med Biol; 2020; 1224():87-115. PubMed ID: 32036607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape.
    Montalbán Del Barrio I; Penski C; Schlahsa L; Stein RG; Diessner J; Wöckel A; Dietl J; Lutz MB; Mittelbronn M; Wischhusen J; Häusler SFM
    J Immunother Cancer; 2016; 4():49. PubMed ID: 27532024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ontogeny of Tumor-Associated Macrophages.
    Laviron M; Boissonnas A
    Front Immunol; 2019; 10():1799. PubMed ID: 31417566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Endless Saga of Monocyte Diversity.
    Canè S; Ugel S; Trovato R; Marigo I; De Sanctis F; Sartoris S; Bronte V
    Front Immunol; 2019; 10():1786. PubMed ID: 31447834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications.
    Sedighzadeh SS; Khoshbin AP; Razi S; Keshavarz-Fathi M; Rezaei N
    Transl Lung Cancer Res; 2021 Apr; 10(4):1889-1916. PubMed ID: 34012800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
    Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
    Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration.
    Bosco MC; Puppo M; Blengio F; Fraone T; Cappello P; Giovarelli M; Varesio L
    Immunobiology; 2008; 213(9-10):733-49. PubMed ID: 18926289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma.
    Pires-Afonso Y; Niclou SP; Michelucci A
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973030
    [No Abstract]   [Full Text] [Related]  

  • 32. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
    Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
    J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tailoring Nanomaterials for Targeting Tumor-Associated Macrophages.
    Ovais M; Guo M; Chen C
    Adv Mater; 2019 May; 31(19):e1808303. PubMed ID: 30883982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Tumor-Associated Myeloid Cells in Breast Cancer.
    Cha YJ; Koo JS
    Cells; 2020 Jul; 9(8):. PubMed ID: 32726950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-associated macrophages: an accomplice in solid tumor progression.
    Chen Y; Song Y; Du W; Gong L; Chang H; Zou Z
    J Biomed Sci; 2019 Oct; 26(1):78. PubMed ID: 31629410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment.
    Van Overmeire E; Stijlemans B; Heymann F; Keirsse J; Morias Y; Elkrim Y; Brys L; Abels C; Lahmar Q; Ergen C; Vereecke L; Tacke F; De Baetselier P; Van Ginderachter JA; Laoui D
    Cancer Res; 2016 Jan; 76(1):35-42. PubMed ID: 26573801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers.
    Fujimura T; Aiba S
    Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32707850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.
    Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T
    Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monocyte heterogeneity and functions in cancer.
    Olingy CE; Dinh HQ; Hedrick CC
    J Leukoc Biol; 2019 Aug; 106(2):309-322. PubMed ID: 30776148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cationic Polymeric Nanoparticle Delivering CCR2 siRNA to Inflammatory Monocytes for Tumor Microenvironment Modification and Cancer Therapy.
    Shen S; Zhang Y; Chen KG; Luo YL; Wang J
    Mol Pharm; 2018 Sep; 15(9):3642-3653. PubMed ID: 29337566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.